STAGE IIIC BREAST CANCER AJCC V7
Clinical trials for STAGE IIIC BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of cancer drugs tested in desperate cases
Disease control TerminatedThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Promising combo for tough breast cancers hits early hurdle
Disease control TerminatedThis early-phase trial tested a combination of targeted drugs (neratinib, pertuzumab, trastuzumab) and chemotherapy (paclitaxel, doxorubicin, cyclophosphamide) in 34 people with advanced or inflammatory breast cancer. The goal was to find the best dose and see if the combo could …
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC